Bayer AG (XTER:BAYN) E10: €0.90 (As of Mar. 2026)


XTER:BAYN Bayer AG XTER:BAYN
62 GF Score
Price €39.59
GF Value €27.37
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG E10?

Bayer AG XTER:BAYN +2.56% 62 E10 is €0.90 as of Mar. 2026. GuruFocus rates XTER:BAYN with a GF Score™ of 62/100 and a GF Value™ of €27.37 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bayer AG's adjusted earnings per share data for the three months ended in Mar. 2026 was €2.810. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.90 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bayer AG's average E10 Growth Rate was -48.90% per year. During the past 3 years, the average E10 Growth Rate was -35.70% per year. During the past 5 years, the average E10 Growth Rate was -20.20% per year. During the past 10 years, the average E10 Growth Rate was -10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bayer AG was 15.10% per year. The lowest was -35.70% per year. And the median was 4.50% per year.

As of today (2026-06-25), Bayer AG's current stock price is €39.59. Bayer AG's E10 for the quarter that ended in Mar. 2026 was €0.90. Bayer AG's Shiller PE Ratio of today is 43.99.

During the past 13 years, the highest Shiller PE Ratio of Bayer AG was 54.10. The lowest was 10.07. And the median was 17.24.


Bayer AG  (XTER:BAYN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bayer AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=39.59/0.90
=43.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bayer AG was 54.10. The lowest was 10.07. And the median was 17.24.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bayer AG E10 Related Terms


Bayer AG E10 Historical Data

* Premium members only.

The historical data trend for Bayer AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG E10 Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.89 3.20 2.54 1.82 0.85

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 1.57 1.32 0.85 0.90

XTER:BAYN vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Shiller PE Ratio falls into.


XTER:BAYN
62GF Score
Bayer AG XTER:BAYN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.81/131.2583*131.2583
=2.810

Current CPI (Mar. 2026) = 131.2583.

Bayer AG Quarterly Data

per share eps CPI Adj_EPS
201606 1.670 100.717 2.176
201609 1.430 101.017 1.858
201612 0.510 101.217 0.661
201703 2.390 101.417 3.093
201706 1.380 102.117 1.774
201709 4.380 102.717 5.597
201712 0.170 102.617 0.217
201803 2.210 102.917 2.819
201806 0.870 104.017 1.098
201809 2.930 104.718 3.673
201812 -4.260 104.217 -5.365
201903 1.270 104.217 1.600
201906 0.410 105.718 0.509
201909 1.050 106.018 1.300
201912 1.440 105.818 1.786
202003 1.520 105.718 1.887
202006 -9.720 106.618 -11.966
202009 -2.790 105.818 -3.461
202012 0.320 105.518 0.398
202103 2.130 107.518 2.600
202106 -2.380 108.486 -2.880
202109 0.090 109.435 0.108
202112 1.180 110.384 1.403
202203 3.350 113.968 3.858
202206 -0.300 115.760 -0.340
202209 0.560 118.818 0.619
202212 0.620 119.345 0.682
202303 2.220 122.402 2.381
202306 -1.920 123.140 -2.047
202309 -4.660 124.195 -4.925
202312 1.370 123.773 1.453
202403 2.040 125.038 2.141
202406 -0.030 125.882 -0.031
202409 -4.260 126.198 -4.431
202412 -0.340 127.041 -0.351
202503 1.320 127.779 1.356
202506 -0.200 128.412 -0.204
202509 -0.980 129.255 -0.995
202512 -3.820 129.361 -3.876
202603 2.810 131.258 2.810

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.90 mean?
Bayer AG (XTER:BAYN) has a E10 of €0.90 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bayer AG and its competitors.
Is Bayer AG's E10 too high?
Bayer AG's current E10 is €0.90. Overall, Bayer AG has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's E10 compare to LLY and JNJ?
Bayer AG's E10 of €0.90 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bayer AG and its competitors. Bayer AG's current E10 is €0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (XTER:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is €27.37, compared to a current price of €39.59 — trading 44.6% above its estimated fair value. The current E10 is €0.90. Bayer AG's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bayer AG (XTER:BAYN), the current E10 is €0.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (XTER:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €39.59 is trading 44.6% above its estimated GF Value™ of €27.37. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for XTER:BAYN:

  • E10: €0.90
  • GF Value™: €27.37 vs. price of €39.59 (44.6% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the XTER:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
62GF Score

Get the complete analysis for XTER:BAYN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.59
Price
€27.37
GF Value